NCT00064363 2012-03-08
Talampanel in Treating Patients With Recurrent High-Grade Glioma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
Teva Branded Pharmaceutical Products R&D, Inc.